Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NVO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Novo Nordisk A/S (NVO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novo Nordisk (NVO) trades at $45.16, down 3.09% today, with bearish technical signals but strong fundamentals. The stock shows robust profitability with 35.35% net margin and 59.82% ROE, supported by consistent earnings beats. Recent developments include positive pediatric obesity trial results for semaglutide and Wegovy pill launch in Germany. Cash flow remains healthy with $10.81B net inflow in 2025, though 2026 projections show a decline.
NVO presents a mixed outlook with strong fundamental metrics offset by technical weakness and competitive pressures. Investment opportunity lies in the expanding GLP-1 market and pipeline developments, while risks include market share loss to Eli Lilly and failed cardiovascular drug trials. Analyst consensus leans bullish with 57.9% buy ratings, but recent prescription slowdown concerns warrant caution.
Read full analysis

Key Stats

  • Market Cap
    $200.69B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $63.98
  • 52W Low
    $35.29
  • Typical Hold Time
    -
  • Enterprise Value
    $215.49B
  • Div Yield
    3.98%
  • Trading Activity
    -
$44.71
52W Low: $35.29
30 Mar 2026
52W High: $63.98
26 Jan 2026

Track Novo Nordisk A/S (NVO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $63.98, highlighting its annual price range. Buy and sell Novo Nordisk A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Most Recent News

Content is generated by Aura AI

Marqeta CEO highlights the company's role in powering diverse fintech innovations with flexible card APIs.

Marqeta CEO Mike Milotich discussed the company's evolution as a modern issuer processor, emphasizing its API platform that enables fintech firms to create personalized card experiences. Over the past decade, Marqeta has supported a wide range of fin...

Market News
4 hours ago
Seeking Alpha
Neutral
Marqeta CEO highlights the company's role in powering diverse fintech innovations with flexible card APIs.

Cream cheese and deli salads recalled over listeria risk in NYC; no illnesses reported yet.

Made Fresh Salads, Inc. has recalled all its cream cheese products and ready-to-eat deli-style salads due to potential listeria contamination. The recall affects various cream cheese flavors and multiple salad types distributed in Brooklyn, Queens, a...

Market News
4 hours ago
Fox Business
Bearish
news icon
Cream cheese and deli salads recalled over listeria risk in NYC; no illnesses reported yet.

Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.

Coinbase CEO Brian Armstrong expressed confidence that the Clarity Act, a U.S. federal bill to regulate digital assets, is likely to pass the Senate with broad support from crypto firms and banks. The legislation aims to clarify oversight between the...

Market News
5 hours ago
CNBC
Bullish
news icon
Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $200.69B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $63.98
  • 52W Low
    $35.29
  • Typical Hold Time
    -
  • Enterprise Value
    $215.49B
  • Div Yield
    3.98%
  • Trading Activity
    -
$44.71
52W Low: $35.29
30 Mar 2026
52W High: $63.98
26 Jan 2026

Track Novo Nordisk A/S (NVO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $63.98, highlighting its annual price range. Buy and sell Novo Nordisk A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!